New combo therapy targets hard-to-treat abdominal cancers in early trial
NCT ID NCT07453875
First seen Mar 07, 2026 · Last updated May 21, 2026 · Updated 8 times
Summary
This early-stage study tests a new treatment plan for people with stomach or colon cancer that has spread to the lining of the abdomen. The approach combines low-dose radiation to the whole abdomen, chemotherapy given directly into the abdomen, and an immunotherapy drug. The main goal is to check if the treatment is safe and tolerable for the 9 to 18 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LDRT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Army Medical Center
Chongqing, Chongqing Municipality, 400042, China
-
Daping Hospital, Army Medical University
Chongqing, Chongqing Municipality, 400042, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.